Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bowen

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Medical Hypotheses|July 17, 2013
The relationship between mood instability and depression: implications for studying and treating depressionR C Bowen, Y Wang, L Balbuena, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
A study of the catabolism of trace amines in mentally disordered individuals with particular reference to agoraphobic patients with panic attacksP H Yu, R C Bowen, B A Davis, et al.
Acta Psychiatrica Scandinavica|March 1, 1983
Platelet monoamine oxidase activity and trace acid levels in plasma of agoraphobic patientsP H Yu, R C Bowen, B A Davis, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 26, 2000
Antidepressants increase gene expression of a neuroprotective enzymeX M Li, A V Juorio, V L Bennett, et al.
Journal of Psychiatry & Neuroscience : JPN|November 1, 1994
Phenelzine reduces plasma vitamin B6D E Malcolm, P H Yu, R C Bowen, et al.
Journal of Psychiatry & Neuroscience : JPN|March 18, 2000
Antidepressants upregulate messenger RNA levels of the neuroprotective enzyme superoxide dismutase (SOD1)X M Li, J Chlan-Fourney, A V Juorio, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 12, 2001
Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activationS S Cui, R C Bowen, G B Gu, et al.
International Clinical Psychopharmacology|January 1, 1991
A comparison of fluoxetine and amitriptyline in the treatment of major depressionD Keegan, R C Bowen, S Blackshaw, et al.
International Clinical Psychopharmacology|January 1, 1994
Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptylineJ S Richardson, D L Keegan, R C Bowen, et al.
Biological Psychiatry|September 15, 1991
Longitudinal effect of amitriptyline and fluoxetine treatment on plasma phenylacetic acid concentrations in depressionB A Davis, A A Boulton, P H Yu, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Medical Hypotheses|July 17, 2013
The relationship between mood instability and depression: implications for studying and treating depressionR C Bowen, Y Wang, L Balbuena, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1983
A study of the catabolism of trace amines in mentally disordered individuals with particular reference to agoraphobic patients with panic attacksP H Yu, R C Bowen, B A Davis, et al.
Acta Psychiatrica Scandinavica|March 1, 1983
Platelet monoamine oxidase activity and trace acid levels in plasma of agoraphobic patientsP H Yu, R C Bowen, B A Davis, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 26, 2000
Antidepressants increase gene expression of a neuroprotective enzymeX M Li, A V Juorio, V L Bennett, et al.
Journal of Psychiatry & Neuroscience : JPN|November 1, 1994
Phenelzine reduces plasma vitamin B6D E Malcolm, P H Yu, R C Bowen, et al.
Journal of Psychiatry & Neuroscience : JPN|March 18, 2000
Antidepressants upregulate messenger RNA levels of the neuroprotective enzyme superoxide dismutase (SOD1)X M Li, J Chlan-Fourney, A V Juorio, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 12, 2001
Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activationS S Cui, R C Bowen, G B Gu, et al.
International Clinical Psychopharmacology|January 1, 1991
A comparison of fluoxetine and amitriptyline in the treatment of major depressionD Keegan, R C Bowen, S Blackshaw, et al.
International Clinical Psychopharmacology|January 1, 1994
Verbal learning by major depressive disorder patients during treatment with fluoxetine or amitriptylineJ S Richardson, D L Keegan, R C Bowen, et al.
Biological Psychiatry|September 15, 1991
Longitudinal effect of amitriptyline and fluoxetine treatment on plasma phenylacetic acid concentrations in depressionB A Davis, A A Boulton, P H Yu, et al.
Pageof 4